Cosentyx is a medication used to treat several inflammatory conditions, including psoriasis, psoriatic arthritis, and ankylosing spondylitis. However, not everyone is a suitable candidate for this medication.

According to the official Cosentyx website, individuals who are allergic to secukinumab, the active ingredient in Cosentyx, should not use this medication [2]. Additionally, individuals with active infections, such as tuberculosis, should avoid using Cosentyx until the infection is treated and resolved [2].

The Medsafe Consumer Medicine Information (CMI) for Cosentyx provides further information on who should avoid using this medication. The CMI states that individuals with a history of inflammatory bowel disease (IBD) should not use Cosentyx, as it may worsen their condition [3]. The CMI also notes that Cosentyx may increase the risk of infections, including serious infections such as sepsis and opportunistic infections [3]. Therefore, individuals with a history of recurrent infections or a weakened immune system should avoid using Cosentyx [3].

Finally, Drug Patent Watch provides information on the approved uses of Cosentyx but does not offer specific guidance on who should avoid using this medication [1].

In summary, individuals who are allergic to secukinumab, have active infections, a history of IBD, recurrent infections, or a weakened immune system should avoid using Cosentyx. It is essential to consult with a healthcare provider before starting any new medication to determine if it is safe and appropriate for your individual needs.

Sources:
[1] https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] https://www.cosentyx.com/safety-and-side-effects
[3] https://www.medsafe.govt.nz/consumers/cmi/c/cosentyx.pdf